InsiderTrades

Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC

Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0000950170-24-029909 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-12 2024-03-08 IRWD MCCOURT Thomas A CEO, Dir M - OptEx $0.00 +120.3K 1.22M +11% $0
D 2024-03-12 2024-03-08 IRWD MCCOURT Thomas A CEO, Dir M - OptEx $0.00 -120.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-03-08 M A 120,298 $0.00 1,217,948 D — —
2 Derivative Performance-based Restricted Stock Unit 2024-03-08 M D 120,298 $0.00 0 D — · — to 2026-02-28 120,298 Class A Common Stock (F3) Additional PSUs may vest upon the Issuer's Class A Common Stock achieving specified prices per share beyond the previously achieved vesting targets. (F2) Each PSU represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs are earned upon the Issuer's Class A Common Stock achieving a specified price per share.